GeneDx Holdings Corp. (WGS)
GeneDx Holdings Market Cap: 2.929B for Jan. 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Labcorp Holdings, Inc. | 22.55B |
| Quest Diagnostics, Inc. | 21.01B |
| Illumina, Inc. | 22.53B |
| Guardant Health, Inc. | 14.81B |
| Delcath Systems, Inc. | 361.61M |
Market Cap Related Metrics
| PE Ratio | 1680.76 |
| PS Ratio | 7.227 |
| Price to Book Value | 10.02 |
| Price to Free Cash Flow | 187.94 |
| Price | 101.35 |
| Earnings Yield | 0.06% |
| Operating PE Ratio | 263.88 |
| Normalized PE Ratio | 520.81 |